Primary Intestinal Lymphangiectasia in Children: Is Octreotide an Effective and Safe Option in the Treatment?

SARI S., Baris Z., DALGIÇ B.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, cilt.51, sa.4, ss.454-457, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 4
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1097/mpg.0b013e3181d1b162
  • Dergi Adı: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.454-457
  • Anahtar Kelimeler: children, intestinal lymphangiectasia, octreotide, ACQUIRED-IMMUNODEFICIENCY-SYNDROME, SLOW-RELEASE OCTREOTIDE, INDUCED PANCREATITIS, SOMATOSTATIN, ABSORPTION, SPHINCTER, THERAPY, PATIENT
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: Octreotide has been suggested as a medical treatment option in refractory cases of primary intestinal lymphangiectasia (IL). There are few data about the long-term effect and safety of octreotide for IL in the literature. In the present article we analyzed pediatric cases of primary IL with long-term octreotide treatment and discussed its safety profile.